Roth Capital Remains Bullish as Flex Pharma (FLKS) Completes NLC Enrollment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Enrollment Completed in Flex Pharma’s Exploratory Human Nocturnal Leg Cramp Study
January 6, 2016 7:00 AM EST-- Company Expects to Report Results Q1 2016 --
BOSTON--(BUSINESS WIRE)-- Flex Pharma, Inc. (NASDAQ: FLKS):
Flex Pharma, Inc. (NASDAQ:... More
